30th Nov 2015 15:21
For filings with the FCA include the annex | |||||
For filings with issuer exclude the annex | |||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | |||||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | Polar Capital Global Healthcare Growth and Income Trust plc | ||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||
An acquisition or disposal of voting rights | |||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
An event changing the breakdown of voting rights | |||||
Other (please specify): | Implementation of Transparency Directive II Regulation | ü | |||
3. Full name of person(s) subject to thenotification obligation: iii | Schroders plc | ||||
4. Full name of shareholder(s) (if different from 3.):iv | Schroder & Co Ltd | ||||
5. Date of the transaction and date onwhich the threshold is crossed orreached: v | 26.11.15 | ||||
6. Date on which issuer notified: | 27.11.15 | ||||
7. Threshold(s) that is/are crossed orreached: vi, vii | Above 5% | ||||
8. Notified details: | |||||||||||||||||
A: Voting rights attached to shares viii, ix | |||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | |||||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||||||||||||
Ord GBP 0.25
GB00B6832P16 | Below 5% | Below 5% | 8,933,914 | 0 | 8,933,914 | 0 |
7.40%
| ||||||||||
B: Qualifying Financial Instruments | |||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||
Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | |||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | |||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to
| % of voting rights xix, xx
| ||||||||||||
| Nominal | Delta | |||||||||||||||
Total (A+B+C) | |||||||||||||||||
Number of voting rights | Percentage of voting rights | ||||||||||||||||
8,933,914 | 7.40% | ||||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | ||
Schroder & Co Limited 8,933,914 7.40%
| ||
Proxy Voting: | ||
10. Name of the proxy holder: | ||
11. Number of voting rights proxy holder will ceaseto hold: | ||
12. Date on which proxy holder will cease to holdvoting rights: | ||
13. Additional information: | This notification is being made based on the legal entity position exceeding 5%. Schroders Plc's position remains within disclosure thresholds as per the previous disclosure. The shares referred to in section 9 are held in portfolios managed by the firm on a discretionary basis for clients under investment management agreements. This disclosure has been calculated based on issue share capital amount 120,775,000 | |
14. Contact name: | Taryn O'Donoghue | |
15. Contact telephone number: | +44 207 658 6000 | |
Related Shares:
Polar Cap GlblSchroders